HIV type 1 Nef is released from infected cells in CD45+ microvesicles and is present in the plasma of HIV-infected individuals

AIDS Research and Human Retroviruses

Volumn 27, Issue 2, 2011, Pages 167-178

  Raymond, A D ^a   Campbell Sims, T C ^a   Khan, M ^a   Lang, M ^a   Huang, M B ^a   Bond, V C ^a   Powell, M D ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; NEF PROTEIN;

APOPTOSIS; ARTICLE; CD4 LYMPHOCYTE COUNT; CELL STRAIN U937; CELL VACUOLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LEUKEMIA CELL LINE; MONOCYTE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; TISSUE CULTURE; VIRUS LOAD;

ANTIGENS, CD45; APOPTOSIS; GENE PRODUCTS, NEF; HIV INFECTIONS; HIV-1; HUMANS; JURKAT CELLS;

EID: 79951687153     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2009.0170     Document Type: Article

References (76)

1. Deacon NJ, Tsykin A, Solomon A, et al.: Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 1995;270(5238):988-991.
2. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, and Desrosiers RC: Brief report: Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 1995;332(4):228-232.
3. Learmont JC, Geczy AF, Mills J, et al.: Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Syd (Pubitemid 29252599)
4. Lewin SR, Lambert P, Deacon NJ, Mills J, and Crowe SM: Constitutive expression of p50 homodimer in freshly isolated human monocytes decreases with in vitro and in vivo differentiation: A possible mechanism influencing human immunodeficiency virus replication in monocytes and mature macrophages. J Virol 1997;71(3):2114-2119. (Pubitemid 27078590)
5. Salvi R, Garbuglia AR, Di CA, et al.: Grossly defective nef gene sequences in a human immunodeficiency virus type 1- seropositive long-term nonprogressor. J Virol 1998;72(5): 3646-3657. (Pubitemid 28188661)
6. Birch MR, Learmont JC, Dyer WB, et al.: An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC). J Clin Virol 2001;22(3):263-270. (Pubitemid 32846557)
7. Gorry PR, Churchill M, Learmont J, Cherry C, Dyer WB, Wesselingh SL, et al.: Replication-dependent pathogenecity of attenuated nef-deleted HIV-1 in vivo. J Acquir Immune Defic Syndr 2007;46:390-394. (Pubitemid 350098688)
8. Greenough TC, Sullivan JL, and Desrosiers RC: Declining CD4 T-cell counts in a person infected with nef-deleted HIV- 1. N Engl J Med 1999;340(3):236-237. (Pubitemid 29063225)
9. Baba TW, Liska V, Khimani AH, et al.: Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat Med 1999;5(2):194-203. (Pubitemid 29068527)
10. Dickie P, Ramsdell F, Notkins AL, and Venkatesan S: Spontaneous and inducible epidermal hyperplasia in transgenic mice expressing HIV-1 Nef. Virology 1993;197(1): 431-438.
11. Dickie P: HIV type 1 Nef perturbs eye lens development in transgenic mice. AIDS Res Hum Retroviruses 1996;12(3): 177-189. (Pubitemid 26054161)
12. Dickie P: Nef modulation of HIV type 1 gene expression and cytopathicity in tissues of HIV transgenic mice. AIDS Res Hum Retroviruses 2000;16(8):777-790. (Pubitemid 30327294)
13. Dickie P, Roberts A, and Lee R: A defect in HIV-1 transgenic murine macrophages results in deficient nitric oxide production. J Leukoc Biol 2001;70(4):592-600. (Pubitemid 32954770)
14. Ho DD, Neumann AU, Perelson AS, et al.: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995;373(6510):123-126.
15. Perelson AS, Essunger P, Cao Y, et al.: Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997;387(6629):188-191. (Pubitemid 27209434)
16. Badley AD, Pilon AA, Landay A, and Lynch DH: Mechanisms of HIV-associated lymphocyte apoptosis. Blood 2000; 96(9):2951-2964.
17. Boya P, Pauleau AL, Poncet D, et al.: Viral proteins targeting mitochondria: Controlling cell death. Biochim Biophys Acta 2004;1659(2-3):178- 189. (Pubitemid 39575505)
18. Chase A, Zhou Y, and Siliciano RF: HIV-1-induced depletion of CD4+ T cells in the gut: Mechanism and therapeutic implications. Trends Pharmacol Sci 2006;27(1):4-7. (Pubitemid 43063116)
19. Huang MB, Jin LL, James CO, et al.: Characterization of Nef-CXCR4 interactions important for apoptosis induction. J Virol 2004;78(20):11084-11096. (Pubitemid 39299649)
20. James CO, Huang MB, Khan M, et al.: Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors. J Virol 2004;78(6):3099-3109. (Pubitemid 38314368)
21. Geyer M, Fackler OT, and Peterlin BM: Structure-function relationships in HIV-1 Nef. EMBO Rep 2001;2(7):580-585. (Pubitemid 32707703)
22. Arold ST and Baur AS: Dynamic Nef and Nef dynamics: How structure could explain the complex activities of this small HIV protein. Trends Biochem Sci 2001;26(6):356-363. (Pubitemid 32530653)
23. Harris M: From negative factor to a critical role in virus pathogenesis: The changing fortunes of Nef. J Gen Virol 1996;77(Pt 10):2379-2392. (Pubitemid 26348358)
24. Garcia JV and Miller AD: Downregulation of cell surface CD4 by nef. Res Virol 1992;143(1):52-55.
25. Hrecka K, Swigut T, Schindler M, Kirchhoff F, and Skowronski J: Nef proteins from diverse groups of primate lentiviruses downmodulate CXCR4 to inhibit migration to the chemokine stromal derived factor 1. J Virol 2005;79(16): 10650-10659. (Pubitemid 41098604)
26. Schwartz O, Marechal V, Le GS, Lemonnier F, and Heard JM: Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 1996;2(3):338-342. (Pubitemid 26080655)
27. Stumptner-Cuvelette P, Morchoisne S, Dugast M, et al.: HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc Natl Acad Sci USA 2001;98(21): 12144-12149. (Pubitemid 32959841)
28. Wildum S, Schindler M, Munch J, and Kirchhoff F: Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection. J Virol 2006;80(16):8047-8059. (Pubitemid 44182305)
29. Erdtmann L, Janvier K, Raposo G, et al.: Two independent regions of HIV-1 Nef are required for connection with the endocytic pathway through binding to the mu 1 chain of AP1 complex. Traffic 2000;1(11):871-883.
30. Geyer M, Yu H, Mandic R, et al.: Subunit H of the V-ATPase binds to the medium chain of adaptor protein complex 2 and connects Nef to the endocytic machinery. J Biol Chem 2002;277(32):28521-28529. (Pubitemid 41079278)
31. Janvier K, Craig H, Le GS, et al.: Nef-induced CD4 downregulation: A diacidic sequence in human immunodeficiency virus type 1 Nef does not function as a protein sorting motif through direct binding to beta-COP. J Virol 2001;75(8):3971-3976. (Pubitemid 32246406)
32. Craig HM, Pandori MW,and Guatelli JC: Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. Proc Natl Acad Sci USA 1998;95(19):11229-11234. (Pubitemid 28450110)
33. Craig HM, Reddy TR, Riggs NL, Dao PP, and Guatelli JC: Interactions of HIV-1 nef with the mu subunits of adaptor protein complexes 1, 2, and 3: Role of the dileucine-based sorting motif. Virology 2000;271(1):9-17. (Pubitemid 30341509)
34. Faure J, Stalder R, Borel C, et al.: ARF1 regulates Nefinduced CD4 degradation. Curr Biol 2004;14(12):1056-1064. (Pubitemid 38791567)
35. Campbell TD, Khan M, Huang MB, Bond VC, and Powell MD: HIV-1 Nef protein is secreted into vesicles that can fuse with target cells and virions. Ethn Dis 2008; 18(2 Suppl 2):S2-S9.
36. Sandrin V and Cosset FL: Intracellular versus cell surface assembly of retroviral pseudotypes is determined by the cellular localization of the viral glycoprotein, its capacity to interact with Gag, and the expression of the Nef protein. J Biol Chem 2006;281(1):528-542. (Pubitemid 43671216)
37. Schwartz O, Utry-Varsat A, Goud B, et al.: Human immunodeficiency virus type 1 Nef induces accumulation of CD4 in early endosomes. J Virol 1995;69(1):528-533. (Pubitemid 24378834)
38. Pan BT, Teng K, Wu C, Adam M, and Johnstone RM: Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes. J Cell Biol 1985;101(3):942-948. (Pubitemid 16256847)
39. Stoorvogel W, Kleijmeer MJ, Geuze HJ, and Raposo G: The biogenesis and functions of exosomes. Traffic 2002;3(5):321-330. (Pubitemid 34461042)
40. Van NG, Raposo G, Candalh C, et al.: Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology 2001;121(2): 337-349. (Pubitemid 32729381)
41. Van NG, Porto-Carreiro I, Simoes S, and Raposo G: Exosomes: A common pathway for a specialized function. J Biochem 2006;140(1):13-21. (Pubitemid 44433541)
42. Jonuleit H, Schmitt E, Steinbrink K, and Enk AH: Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol 2001;22(7):394-400. (Pubitemid 32673646)
43. Raposo G, Nijman HW, Stoorvogel W, et al.: B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996;183(3): 1161-1172. (Pubitemid 26113979)
44. Thery C, Duban L, Segura E, et al.: Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol 2002;3(12):1156-1162. (Pubitemid 35469700)
45. Vincent-Schneider H, Stumptner-Cuvelette P, Lankar D, et al.: Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells. Int Immunol 2002;14(7):713-722. (Pubitemid 34814631)
46. Heijnen HF, Debili N, Vainchencker W, et al.: Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules. Blood 1998;91(7):2313-2325. (Pubitemid 28155504)
47. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, and Sixma JJ: Activated platelets release two types of membrane vesicles: Microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999;94(11):3791-3799.
48. Trams EG, Lauter CJ, Salem N Jr., and Heine U: Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta 1981;645(1):63-70.
49. Bess JW, Jr., Gorelick RJ, Bosche WJ, Henderson LE, and Arthur LO: Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations. Virology 1997;230(1):134-144. (Pubitemid 27243529)
50. Gluschankof P, Mondor I, Gelderblom HR, and Sattentau QJ: Cell membrane vesicles are a major contaminant of gradient-enriched human immunodeficiency virus type-1 preparations. Virology 1997;230(1):125-133. (Pubitemid 27243528)
51. Ali SA, Huang MB, Campbell PE, et al.: Genetic characterization of HIV type 1 Nef-induced vesicle secretion. AIDS Res Hum Retroviruses 2010;26(2):173-192.
52. Cantin R, Diou J, Belanger D, Tremblay AM, and Gilbert C: Discrimination between exosomes and HIV-1: Purification of both vesicles from cell-free supernatants. J Immunol Methods 2008;338(1-2):21-30.
53. Esser MT, Graham DR, Coren LV, et al.: Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: Implications for viral pathogenesis and immune regulation. J Virol 2001;75(13):6173-6182. (Pubitemid 32553148)
54. Wubbolts R, Leckie RS, Veenhuizen PT, et al.: Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem 2003;278(13):10963- 10972. (Pubitemid 36792644)
55. Trubey CM, Chertova E, Coren LV,et al.: Quantitation of HLA class II protein incorporated into human immunodeficiency type 1 virions purified by anti-CD45 immunoaffinity depletion of microvesicles. J Virol 2003;77(23):12699-12709. (Pubitemid 37430665)
56. Fujii Y, Otake K, Tashiro M, and Adachi A: Soluble Nef antigen of HIV-1 is cytotoxic for human CD4+ T cells. FEBS Lett 1996;393(1):93-96. (Pubitemid 26298237)
57. Oh SK, Cruikshank WW, Raina J, et al.: Identification of HIV- 1 envelope glycoprotein in the serum of AIDS and ARC patients. J Acquir Immune Defic Syndr 1992;5(3):251-256.
58. Xiao H, Neuveut C, Tiffany HL, et al.: Selective CXCR4 antagonism by Tat: Implications for in vivo expansion of coreceptor use by HIV-1. Proc Natl Acad Sci USA 2000; 97(21):11466-11471.
59. Chaudhry A, Das SR, Jameel S, et al.: HIV-1 Nef induces a Rab11-dependent routing of endocytosed immune costimulatory proteins CD80 and CD86 to the Golgi. Traffic 2008; 9(11):1925-1935.
60. Lenassi M, Cagney G, Liao M, et al.: HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic 2010;11(1):110-122.
61. Chertova E, Chertov O, Coren LV, et al.: Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J Virol 2006;80(18):9039-9052. (Pubitemid 44359978)
62. Muratori C, Cavallin LE, Kratzel K, et al.: Massive secretion by T cells is caused by HIV Nef in infected cells and by Nef transfer to bystander cells. Cell Host Microbe 2009;6(3): 218-230.
63. Khan M, Jin L, Huang MB, et al.: Chimeric human immunodeficiency virus type 1 (HIV-1) virions containing HIV-2 or simian immunodeficiency virus Nef are resistant to cyclosporine treatment. J Virol 2004;78(4):1843-1850. (Pubitemid 38176715)
64. Khan M, Jin L, Miles L, Bond VC, and Powell MD: Chimeric human immunodeficiency virus type 1 virions that contain the simian immunodeficiency virus nef gene are cyclosporin A resistant. J Virol 2005;79(5):3211-3216. (Pubitemid 40270603)
65. Khan M, Garcia-Barrio M, and Powell MD: Restoration of wild-type infectivity to human immunodeficiency virus type 1 strains lacking nef by intravirion reverse transcription. J Virol 2001;75(24):12081-12087. (Pubitemid 33115880)
66. NguyenDHand Hildreth JE: Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipidenriched membrane lipid rafts. J Virol 2000;74(7):3264-3272. (Pubitemid 30143751)
67. Kotov A, Zhou J, Flicker P, and Aiken C: Association of Nef with the human immunodeficiency virus type 1 core. J Virol 1999;73(10):8824-8830. (Pubitemid 29441749)
68. Fackler OT, Moris A, Tibroni N, et al.: Functional characterization of HIV-1 Nef mutants in the context of viral infection. Virology 2006;351(2):322-339. (Pubitemid 44108070)
69. Kasper MR, Roeth JF, Williams M, et al.: HIV-1 Nef disrupts antigen presentation early in the secretory pathway. J Biol Chem 2005;280(13):12840- 12848.
70. Olivetta E, Percario Z, Fiorucci G, et al.: HIV-1 Nef induces the release of inflammatory factors from human monocyte/ macrophages: Involvement of Nef endocytotic signals and NF-kappa B activation. J Immunol 2003;170(4):1716-1727. (Pubitemid 36197386)
71. Piguet V, Gu F, Foti M, et al.: Nef-induced CD4 degradation: A diacidic-based motif in Nef functions as a lysosomal targeting signal through the binding of beta-COP in endosomes. Cell 1999;97(1):63-73. (Pubitemid 29165890)
72. Roeth JF, Williams M, Kasper MR, Filzen TM, and Collins KL: HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail. J Cell Biol 2004;167(5):903-913. (Pubitemid 39628112)
73. Geijtenbeek TB, Kwon DS, Torensma R, et al.: DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000;100(5):587-597.
74. McDonald D, Wu L, Bohks SM, et al.: Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 2003;300(5623):1295-1297. (Pubitemid 36618241)
75. Turville S, Wilkinson J, Cameron P, Dable J, and Cunningham AL: The role of dendritic cell C-type lectin receptors in HIV pathogenesis. J Leukoc Biol 2003;74(5):710-718. (Pubitemid 38040347)
76. Li Q, Duan L, Estes JD, et al.: Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 2005;434(7037):1148-1152. (Pubitemid 40663495)